We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-3 of 3

FDA regulatory and compliance monthly recap December 2015
  • Loeb & Loeb LLP
  • USA
  • January 6 2016

The pharmaceutical industry won in its latest bid for more leeway to promote drugs for unapproved uses, as the Food and Drug Administration agreed to

Scott S. Liebman
  • Loeb & Loeb LLP